Literature DB >> 11066866

Awakening as a change process among women at risk for HIV who engage in survival sex.

C Mallory1, P N Stern.   

Abstract

Women who exchange sex for survival requirements risk exposure to the human immunodeficiency virus (HIV). This grounded theory study was conducted to better understand these women's concerns, attitudes, and behaviors related to HIV, with the goal of informing prevention research. Interviews with 11 women engaged in survival sex were analyzed. Women described sliding into survival sex as a result of economic crises. Survival sex exposed women to violence, drug use, sexually transmitted infections, and HIV. Mitigating these risks is a process of awakening in which women reconstruct risk and survival and make changes in their behavior. These findings highlight the complexity of the problem of survival sex and suggest interventions to help women protect themselves against HIV.

Entities:  

Mesh:

Year:  2000        PMID: 11066866     DOI: 10.1177/104973200129118660

Source DB:  PubMed          Journal:  Qual Health Res        ISSN: 1049-7323


  4 in total

1.  Gender and race as correlates of high risk sex behaviors among injection drug users at risk for HIV enrolled in the HPTN 037 study.

Authors:  Mandy J Hill; Michael Holt; Brett Hanscom; Zhe Wang; Marylou Cardenas-Turanzas; Carl Latkin
Journal:  Drug Alcohol Depend       Date:  2018-01-04       Impact factor: 4.492

2.  A syndemic analysis of alcohol use and sexual risk behavior among tourism employees in Sosúa, Dominican Republic.

Authors:  Mark B Padilla; Vincent Guilamo-Ramos; Ramona Godbole
Journal:  Qual Health Res       Date:  2011-08-22

3.  Young urban women's patterns of unprotected sex with men engaging in HIV risk behaviors.

Authors:  Rachel Jones; Marsha Oliver
Journal:  AIDS Behav       Date:  2006-12-08

Review 4.  Poverty, unstable housing, and HIV infection among women living in the United States.

Authors:  Elise D Riley; Monica Gandhi; C Hare; Jennifer Cohen; Stephen Hwang
Journal:  Curr HIV/AIDS Rep       Date:  2007-12       Impact factor: 5.495

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.